Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
Operating Income | ($75.8M) | ($74.4M) | ($15.1M) | ($115.0M) | ($68.7M) | ($29.5M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hims & Hers Health, Inc.'s last 12-month Operating Income is $35.2M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Hims & Hers Health, Inc.'s Operating Income growth was N/A. The average annual Operating Income growth rates for Hims & Hers Health, Inc. have been N/A over the past three years, N/A over the past five years.